Brigham and Women’s Hospital’s TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, without an apparent increase in hemorrhagic stroke.
Study background and patient population
Patients with prior ischemic stroke face a high risk for recurrence and other cardiovascular events. Previous randomized trials of PCSK9 inhibitors and ezetimibe showed benefits of intensive LDL-cholesterol reduction in unselected atherosclerotic disease populations. Limited data existed for the specific subgroup with prior ischemic stroke, leaving uncertainty about the benefits and safety of achieving very low LDL-cholesterol levels in this cohort.
In the study, “Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke,” published as an accepted manuscript in Circulation, researchers analyzed data from FOURIER and its open-label extension to examine the relationship between achieved LDL-cholesterol and long-term incidence of a composite cardiovascular endpoint and stroke outcomes.
Analysis included 5,291 patients with prior ischemic stroke more than 4 weeks before enrollment. Median age was 65 years with 34.1% women. Median time from prior stroke to trial entry was 3.3 years.
LDL-cholesterol categories and outcomes
LDL-cholesterol categories included under 20 mg/dL for 666 patients, 20 to 39 mg/dL for 1,410 patients, 40 to 54 mg/dL for 586 patients, 55 to 69 mg/dL for 508 patients, and 70 mg/dL or more for 2,121 patients.
Analyses demonstrated monotonic decreases in the adjusted annualized incidence of the primary composite and key secondary composite with lower achieved LDL-cholesterol levels on a continuous scale, with p-trend <0.001 for each.
Compared with ≥70 mg/dL, LDL-cholesterol <40 mg/dL corresponded to an incidence rate ratio of 0.69 for the primary endpoint and 0.73 for the key secondary endpoint.
Stroke recurrence
Recurrent stroke incidence declined as LDL-cholesterol decreased for all stroke and ischemic stroke.
Comparison of <40 mg/dL with ≥70 mg/dL yielded an incidence rate ratio of 0.73 for all stroke and 0.75 for ischemic stroke. Hemorrhagic stroke events were infrequent and showed no relationship to achieved LDL-cholesterol with a p-trend of 0.85.
Patients with prior ischemic stroke receiving lipid-lowering therapy, lower LDL-cholesterol below 40 mg/dL appeared to be associated with lower incidence of major adverse cardiovascular events and recurrent stroke.
Findings tentatively support consideration of more intensive LDL-cholesterol lowering in this population.
Written for you by our author Justin Jackson, edited by Gaby Clark, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You’ll get an ad-free account as a thank-you.
More information: Victorien Monguillon et al, Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke, Circulation (2025). DOI: 10.1161/circulationaha.125.077549
News
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
